Daewoong Pharmaceutical Co. Ltd.

KQ:069620 Korea Other
Market Cap
$1.06 Million
₩1.56 Billion KRW
Market Cap Rank
#35880 Global
#2139 in Korea
Share Price
₩162200.00
Change (1 day)
-1.70%
52-Week Range
₩113000.00 - ₩194000.00
All Time High
₩270845.41
About

Daewoong Pharmaceutical Co. Ltd. operates in Diversified Metals & Mining.

Daewoong Pharmaceutical Co. Ltd. (069620) - Net Assets

Latest net assets as of : ₩- KRW

Based on the latest financial reports, Daewoong Pharmaceutical Co. Ltd. (069620) has net assets worth ₩- KRW as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Daewoong Pharmaceutical Co. Ltd. - Net Assets Trend (None–None)

This chart illustrates how Daewoong Pharmaceutical Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Daewoong Pharmaceutical Co. Ltd. (None–None)

The table below shows the annual net assets of Daewoong Pharmaceutical Co. Ltd. from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to Daewoong Pharmaceutical Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

Daewoong Pharmaceutical Co. Ltd. Competitors by Market Cap

The table below lists competitors of Daewoong Pharmaceutical Co. Ltd. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Daewoong Pharmaceutical Co. Ltd.'s equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares Daewoong Pharmaceutical Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently Daewoong Pharmaceutical Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares Daewoong Pharmaceutical Co. Ltd.'s net assets metrics with peer companies in the Other industry.

Industry Context

  • Industry: Other
  • Average net assets among peers: $94,654,706,369
  • Average return on equity (ROE) among peers: -12.73%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Daewoong Pharmaceutical Co. Ltd. (069620) ₩- N/A N/A $1.08 Million
Kukyoung G&M (006050) $51.01 Billion -2.56% 0.37x $8.53K
Kossen Co Ltd (009730) $22.14 Billion -46.64% 1.51x $3.70K
Haansoft (030520) $452.54 Billion 8.20% 0.60x $138.56K
BIT Computer (032850) $54.93 Billion 11.85% 0.29x $30.10K
Plumb Fast Co (035200) $36.27 Billion 5.88% 0.12x $22.68K
A-Frontier Co. Ltd. (036180) $25.85 Billion 16.56% 0.27x $3.60K
Infraware (041020) $64.40 Billion 20.35% 0.18x $29.58K
Kook Soon Dang Co. Ltd. (043650) $204.96 Billion -2.49% 0.23x $26.32K
Stcube (052020) $19.12 Billion -86.05% 0.38x $48.28K
Fourth-Link Inc. (056730) $15.32 Billion -52.44% 1.70x $2.86K